The anti-obesity drugs market was valued at USD 3.2 billion in 2023, driven by the rising prevalence of obesity across the 8 major markets. The market is expected to grow at a CAGR of 43.72% during the forecast period of 2024-2032, with values likely to reach USD 92.3 billion by 2032. The increasing adoption of sedentary lifestyles, coupled with po